uric acid has been researched along with Tremor in 6 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The progression rate was faster in the tremor domain than the nontremor domain before levodopa treatment." | 4.12 | Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling. ( Chan, J; Goetz, CG; Luo, S; Macklin, EA; Oakes, D; Schwarzschild, MA; Simuni, T; Stebbins, GT; Zou, H, 2022) |
| "The aim of this study was to evaluate serum uric acid (UA) levels and serum uric acid/creatinine ratios (UA/Cr) in patients with non-tremor dominant (NTD) Parkinson's disease (PD) compared to tremor dominant (TD) PD and healthy controls (HC)." | 3.81 | Association between serum uric acid and motor subtypes of Parkinson's disease. ( Kulkantrakorn, K; Lolekha, P; Wongwan, P, 2015) |
| "In this study we aimed at evaluating the modifications in the pharmacokinetic profile of cyclosporin A (CyA) after conversion from standard formulation (CyA-ST) to a new formulation (CyA-NF, Sandimmun Neoral) in patients with rheumatoid arthritis (RA)." | 2.69 | Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients. ( Battafarano, N; Fantini, F; Leoni, L; Marchesoni, A; Padula, A; Pasero, G; Ruiu, G; Taglione, E; Zeni, S, 1998) |
| "Uric acid levels were not significantly different between the TD and PIGD subtypes." | 1.48 | Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study. ( Acharyya, S; Au, WL; Chia, NS; Huang, X; Lu, ZH; Ng, E; Ng, SY; Setiawan, F; Tan, EK; Tan, LC; Tay, KY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, S | 1 |
| Zou, H | 1 |
| Stebbins, GT | 1 |
| Schwarzschild, MA | 1 |
| Macklin, EA | 1 |
| Chan, J | 1 |
| Oakes, D | 1 |
| Simuni, T | 1 |
| Goetz, CG | 1 |
| Huang, X | 1 |
| Ng, SY | 1 |
| Chia, NS | 1 |
| Acharyya, S | 1 |
| Setiawan, F | 1 |
| Lu, ZH | 1 |
| Ng, E | 1 |
| Tay, KY | 1 |
| Au, WL | 1 |
| Tan, EK | 1 |
| Tan, LC | 1 |
| Lolekha, P | 1 |
| Wongwan, P | 1 |
| Kulkantrakorn, K | 1 |
| Shils, ME | 1 |
| Patier, JL | 1 |
| San Millán, J | 1 |
| Serrano, M | 1 |
| Marchesoni, A | 1 |
| Fantini, F | 1 |
| Battafarano, N | 1 |
| Zeni, S | 1 |
| Ruiu, G | 1 |
| Padula, A | 1 |
| Taglione, E | 1 |
| Pasero, G | 1 |
| Leoni, L | 1 |
1 trial available for uric acid and Tremor
| Article | Year |
|---|---|
Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Biological Availability; Blood Pressure; Chemistry, Pharma | 1998 |
5 other studies available for uric acid and Tremor
| Article | Year |
|---|---|
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
Topics: Bayes Theorem; Humans; Inosine; Levodopa; Parkinson Disease; Severity of Illness Index; Tremor; Uric | 2022 |
Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study.
Topics: Aged; Cohort Studies; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease | 2018 |
Association between serum uric acid and motor subtypes of Parkinson's disease.
Topics: Aged; Antioxidants; Biomarkers; Creatinine; Disease Progression; Female; Humans; Male; Middle Aged; | 2015 |
EXPERIMENTAL HUMAN MAGNESIUM DEPLETION. I. CLINICAL OBSERVATIONS AND BLOOD CHEMISTRY ALTERATIONS.
Topics: Biomedical Research; Blood Chemical Analysis; Calcium; Calcium, Dietary; Cholesterol; Electromyograp | 1964 |
[Young woman with depression, tremors, generalized dystonia and hypouricemia].
Topics: Adult; Brain; Depression; Dystonia; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonanc | 1994 |